Bisphosphonate Risedronate Reduces Metastatic Human Breast Cancer Burden in Bone in Nude Mice

Cancer Research

Volumn 55, Issue 16, 1995, Pages 3551-3557

  Sasaki, Akira ^a   Boyce, Brendan F ^b   Story, Beryl ^b   Wright, Kenneth R ^b   Chapman, Mark ^c   Boyce, Rogely ^c   Mundy, Gregory R ^a   Yoneda, Toshiyuki ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Department of Pathology ^*  (United States)

^c SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RISEDRONIC ACID;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INHIBITION; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; OSTEOLYSIS; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR VOLUME;

ANIMAL; BONE NEOPLASMS; BONE RESORPTION; BREAST NEOPLASMS; CACHEXIA; DIPHOSPHONATES; ETIDRONIC ACID; HUMAN; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029101805     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Elte, J. W. F., Bijvoet, O. L. M., Clcton, F. J., van-Oosterom, A. T., and Sleeboom, H. P. Osteolytic bone metastases in breast carcinoma. Pathogenesis, morbidity and bisphosphonate treatment. Eur. J. Cancer Clin. Oncol., 22: 493–500, 1986.
2. Holten-Verzantoot, A. T. V., Bijvoet, O. L. M., Cleton, F. J., Hermans, J., Kroon, H. M., Harinck, H. I. J., Vermery, P., Elte, J. W. F., Neijt, J. P., Beex, L. V. A. M., and Blijham, G. Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment. Lancet, 31: 983–985, 1987.
3. Yoneda, T., Sasaki, A., and Mundy, G. R. Osteolytic bone disease in breast cancer. Breast Cancer Res. Treat., 32: 73–84, 1994.
4. Fleisch, H. Bisphosphonates. Pharmacology and use in the treatment of tumor-induced hypercalcemia and metastatic bone disease. Drugs, 42: 919–944, 1991.
5. Boyde, A., Maconnachie, E., Reid, S. A., Delling, G., and Mundy, G. R. Scanning electron microscopy in bone pathology: review of methods. Potential and applications. Scanning Electron Microsc., 4: 1537–1554, 1986.
6. Arguello, F. B., Baggs, R. B., and Frantz, C. N. A murine model of experimental metastasis to bone and bone marrow. Cancer Res., 48: 6876–6881, 1988.
7. Nakai, M., Mundy, G. R., Williams, P. J., Boyce, B. F., and Yoneda, T. A synthetic antagonist to laminin inhibits the formation of osteolytic metastases by human melanoma cells in nude mice. Cancer Res., 52: 5395–5399, 1992.
8. Cailleau, R., Yong, R., Olive, M., and Reeves, W. J. Breast tumor cell lines from pleural effusions. J. Natl. Cancer Inst., 53: 661–674, 1974.
9. Arguello, F., Fulanetto, R. W., Baggs, R. B., Graves, B. T., Harwell, S. E., Cohen, H. J., and Frantz, C. N. Incidence and distribution of experimental metastases in mutant mice with defective organ microenvironment (Genotype Sl/Sld and W/Wv). Cancer Res., 52: 2304–2309, 1992.
10. Yoneda, T., Aufdemorte, T. B., Nishimura, R., Nishikawa, N., Sakuda, M., Alsina, M. M., Chavez, J. B., and Mundy, G. R. Occurrence of hypercalcemia and leukocytosis with cachexia in a human squamous cell carcinoma of the maxilla in athymic nude mice. A novel experimental model of three concomitant paraneoplastic syndromes. J. Clin. Oncol., 9: 468–477, 1991.
11. Sabatini, M., Boyce, B., Aufdemorte, T., Bonewald, L., and Mundy, G. R. Infusions of recombinant human interleukin-1 α and β cause hypercalcemia in nomal mice. Proc. Natl. Acad. Sci. USA, 85: 5235–5239, 1988.
12. Boyce, R. W., Wronski, T. J., Ebert, D. C., Stevens, M. L., Paddock, C. L., Youngs, T. A., and Gundersen, H. J. G. Direct stereological estimation of three-dimensional connectivity in rat vertebrae: effect of estrogen, etidronate and risedronate following ovariectomy. Bone (Elmsford), 16: 209–213, 1995.
13. Dawson-Saunders, B., and Trapp, R. G. Methods for analyzing survival data. In: B. Dawson-Saunders and R. G. Trapp (eds.), Basic and Clinical Biostatistics, Ed. 2, pp. 188–209. Norwalk, CT: Appleton and Lange, 1994.
14. Hall, D. G., and Stoica, G. Effect of the bisphosphonate risedronate on bone metastases in a rat mammary adenocarcinoma model system. J. Bone Miner. Res., 9: 221–230, 1994.
15. Sato, M., Grasser, W., Endo, N., Akins, R., Simmons, H., Thompson, D. D., Golub, E., and Rodan, G. A. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J. Clin. Invest., 88: 2094–2105, 1991.
16. Hauschka, P. V., Manrakos, A. E., Iafrati, M. D., Doleman, S. E., and Klagsbrun, M. Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-sepharose. J. Biol. Chem., 261: 12665–12674, 1986.
17. Pfeilschifter, J., and Mundy, G. R. Modulation of transforming growth factor beta activity in bone cultures by osteotropic hormones. Proc. Natl. Acad. Sci. USA, 84: 2024–2028, 1987.
18. Paget, S. The distribution of secondary growths in cancer of the breast. Lancet, 1: 571–573, 1989.
19. Mundy, G. R., and Yoneda, T. Facilitation and suppression of bone metastasis. Clin. Orthop. Relat. Res., 312: 34–44, 1995.
20. Paterson, A. H. G., Ernst, D. S., Powles, T. J., Ashley, S., McCloskey, E. V., and Kanis, J. A. Treatment of skeletal disease in breast cancer with clodronate. Bone (Elmsford), 12: S25-S30, 1991.
21. Patel, J. K., Nemoto, T., Vezeridis, M., Petrell, N., Suh, O., and Dao, T. L. Does more intense palliative treatment improve overall survival in metastatic breast cancer patient. Cancer (Phila.), 57: 567–570, 1986.
22. Coates, A., Gebski, V., Bishop, J. F., Jeal, P. N., Woods, R. L., Harvery, V., Gill, G., Simpson, J., Drummond, R., Bromne, J., Cooten, R. V., and Forbes, J. F. Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. N. Engl. J. Med., 317: 1490–1495, 1987.
23. Krempien, B., and Manegold., C. Prophylactic treatment of skeletal metastases, tumor-induced osteolysis, and hypercalcemia in rats with the bisphosphonate C12MBP. Cancer (Phila.), 72: 91–98, 1993.
24. Arguello, F., Baggs, R. B., Duerst, R. E., Johnstone, L., McQueen, K., Frantz, C. N. Pathogenesis of vertebral metastasis and epidural spinal cord compression. Cancer (Phila.), 65: 98–106, 1990.
25. Kostenuik, P. J., Orr, F. W., Suyama, K., and Singh, G. Increased growth rat and tumor burden of spontaneously metastatic Walker 256 cancer cells in the skeleton of bisphosphonate-treated rats. Cancer Res., 53: 5452–5457, 1993.